Guardant Health, Inc. (NASDAQ:GH) Q3 2023 Earnings Call Transcript November 6, 2023 Guardant Health, Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.93. Operator: Hello, everyone, and welcome to the Guardant Health Q3 2023 Earnings Call. My name is Thrisha, and I’ll be your operator today. [Operator Instructions] I will now hand you […]
Access to care for the highly preventable disease is thought to be behind why Black Americans are 20% more likely to receive a colorectal cancer diagnosis than any other racial or ethnic group.
Can personalized care prevent excessive screening for colorectal cancer in older adults? medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Noninvasive multitarget stool RNA test found to have high sensitivity for colorectal neoplasia medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.